BURGESS HILL, England, September 1 /PRNewswire-FirstCall/ --
With some 20,000 UK children with Type 1 diabetes(i) about to start the new school year, new guidance from the National Institute for Health and Clinical Excellence (NICE) looks set to revolutionise the way children manage their diabetes, granting more freedom and control for their condition, by greater access to insulin pump therapy. The new recommendations finally acknowledge key research(ii) supported by Roche, that shows the positive impact of pumps on quality of life for sufferers and their families.
Roche, a world leader in diabetes care and management services, has been working closely with diabetes healthcare specialists to raise awareness of pump therapy and encourage and support new users. Roche welcomes the new guidelines that recommend greater access to insulin pump therapy to manage Type 1 diabetes, particularly amongst children and young people, with pumps replacing traditional insulin injections which have been shown to interrupt the school day(iii).
Dr Katharine Barnard PhD, School of Psychology at the University of Southampton, one of the UK's leading authorities into quality of life issues surrounding insulin pumps in Type 1 diabetes, who has worked with Roche says: "There are significant psychosocial benefits associated with insulin pump therapy, particularly improved quality of life. The new NICE guidelines should facilitate greater access to this therapy, which will only be good news for patients and their families. For children it should have a positive impact on both their school and home life."
Benefits of replacing injections with insulin pump therapy include fewer hypoglycaemic episodes, the opportunity to participate in sports without having to plan ahead and the choice to eat a wider variety of food as the pump can be easily adjusted to supply the right amount of insulin each moment of the day.
Britain is lagging behind other major count
Copyright©2008 PR Newswire.
All rights reserved